Principal, Roivant Health

Since its inception in 2014, Roivant Sciences has sought to improve health by rapidly delivering innovative medicines and technologies to patients. We’ve employed a unique, decentralized model of nimble, focused companies (‘Vants’) focused on various therapeutic areas and built around the pursuit of innovation in drug development and technology.

Our model is different. Five new medicines have been approved off the Roivant platform; we’ve built five biotechs that have